Annick Moens

5PUBLICATIONS
13CO-AUTHORS
Medical infection agents (incl. prions)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Obstetrics and gynaecologyFoetal development and medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 12, 2022
Pneumocystis jirovecii Pneumonia in Patients with Inflammatory Bowel Disease-a Case Series.

Sophie Vieujean, Annick Moens, Deborah Hassid

|Apr 20, 2022
Safety of sequential biological therapy in inflammatory bowel disease: results from a tertiary referral centre.

Annick Moens, Nasim Sadat Seyed Tabib, Vera Ballet

|Nov 09, 2021
Translating Results from VARSITY to Real World: Adalimumab vs Vedolizumab as First-line Biological in Moderate to Severe IBD.

Annick Moens, Bram Verstockt, Dahham Alsoud

|Nov 07, 2019
Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti-TNF or conventional therapy: results of the European CONCEIVE study.

Annick Moens, C Janneke van der Woude, Mette Julsgaard

Pageof 1